“We are poised to dominate this field:” Sen. Toomey on biotech; PA, MN Congressmen want new medical device tax repealed [VIDEO]
As if the Obama Administration’s healthcare bill —The Affordable Care Act — wasn’t under enough fire this week with the start of Supreme Court hearings yesterday, medical technology trade organization AdvaMed held a press conference with congressmen from Pennsylvania and Minnesota to call for the repeal of the medical device tax instated by the bill and herald the release of a new report that benchmarks the competitiveness of the medical technology industry in the United States.
U.S. Senator Pat Toomey (PA), U.S. Rep. Jim Gerlach (6th-PA), U.S. Rep. Pat Meehan (7th-PA), Co-chair of the Congressional Med Tech Caucus U.S. Rep. Erik Paulsen (3rd-MN), and U.S. Rep. Charlie Dent (15th-PA) joined the University City Science Center’s Stephen Tang, David Nexon of AdvaMed and other leaders of the Pennsylvania bio tech industry at Quorum to discuss the negative impact the new 2.3 percent tax would have on U.S. competitiveness in the global biotech market.
The tax, which is scheduled to take effect in 2013, could apply to a range of medical devices from retail products like hearing aids to advanced medical technology, like MRIs, according to an AdvaMed press release. AdvaMed estimates the tax could result in the loss of up to 43,ooo jobs across the United States and views the tax as a threat to America’s competitiveness in the global medical technology market.
“Now our tax system is so uncompetitive for high-tech manufacturing industries like ours that the taxes our government applies to activities conducted in the U.S. are two and a half times higher than taxes foreign government levy on those same activities abroad,” said Nexon.













